Clinical Trials on Castrate-Resistant Prostate Cancer
Total 5613 results
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Université de SherbrookeCanadian Cancer Society (CCS); Fonds de la Recherche en Santé du Québec; Merck... and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerCanada
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Rabin Medical CenterUniversity of TorontoCompletedDeath | Metastasis | Castration-resistant Prostate CancerCanada
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
University of Southern CaliforniaNational Cancer Institute (NCI); Mayo ClinicActive, not recruitingBreast Cancer | Recurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMetastatic Castration-resistant Prostate Cancer, mCRPCChina
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
BayerRecruitingNon-metastatic Castration-resistant Prostate CancerIndia
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Advanced Accelerator ApplicationsNo longer availableMetastatic Castration-resistant Prostate Cancer (mCRPC)
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingMetastatic Castration-resistant Prostate CancerGermany
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaRecruitingMetastatic Castration-resistant Prostate CancerFrance
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
University of UtahExelixisRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BAMF HealthTelix International Pty LtdRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
FutureChemRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
Sunnybrook Health Sciences CentreRecruitingOligoprogressive | Castration-Resistant Prostate CancerCanada
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Laekna LimitedActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Korea, Republic of
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Williams Cancer FoundationSyncromune, Inc.Active, not recruitingPhase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMexico
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Castration Resistant Prostate CancerFrance, United States, Spain, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Terminated
-
Peking Union Medical College HospitalCompletedMetastatic Castration-resistant Prostate CancerChina
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
ARTBIO Inc.Completed
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
National University Hospital, SingaporeNational University of SingaporeActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Hormone Sensitive Prostate CancerSingapore